PPIB
protein-codingpeptidylprolyl isomerase B, the group of Cyclophilin peptidylprolyl isomerases
Gene summary
The protein encoded by this gene is a cyclosporine-binding protein and is mainly located within the endoplasmic reticulum. It is associated with the secretory pathway and released in biological fluids. This protein can bind to cells derived from T- and B-lymphocytes, and may regulate cyclosporine A-mediated immunosuppression. Variants have been identified in this protein that give rise to recessive forms of osteogenesis imperfecta. [provided by RefSeq, Oct 2009]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~7.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0008148
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0009805
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0008147
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0009805
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0009805
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0009804
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Musculoskeletal
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PPIB variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000942.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 5 | 40 | 1 | 46 | ||
| missense | 1 | 5 | 57 | 3 | 66 | |
| nonsense | 2 | 2 | 4 | |||
| start loss | 1 | 1 | ||||
| frameshift | 5 | 5 | 1 | 11 | ||
| splice donor/acceptor (+/-2bp) | 1 | 3 | 7 | 11 | ||
| Total | 9 | 14 | 72 | 43 | 1 | 139 |
Highest pathogenic variant AF is 0.000010945574
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000933.1 | 5 | MANE Select | |
| Ensembl | ENSP00000300026.4 | 5 | MANE Select | |
| Ensembl | ENSP00000504873.1 | 4 | Standard | |
| Ensembl | ENSP00000506584.1 | 5 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Ibuprofen Action Pathway
- Phenytoin (Antiarrhythmic) Action Pathway
- Ibuprofen Metabolism Pathway
- Morphine Metabolism Pathway
- Irinotecan Action Pathway
Biological Process
- protein peptidyl-prolyl isomerization
- positive regulation of multicellular organism growth
- protein refolding
- positive regulation by host of viral process
- positive regulation by host of viral genome replication
Molecular Function
- RNA binding
- peptidyl-prolyl cis-trans isomerase activity
- protein binding
- collagen binding
- cyclosporin A binding
Cellular Component
- nucleus
- endoplasmic reticulum
- endoplasmic reticulum lumen
- focal adhesion
- membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000300026
- Coding exons
- 5
- Length
- 7394
- Individuals with no LoFs
- 125722
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 26
- Defined
- 125748
- p
- 0.000103
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.299 | 119 | 129 | 0.926 | 0.00000768 | 1416 |
| Missense (PolyPhen) | 43 | 53.453 | 0.80444 | 589 | ||
| Synonymous | -1.12 | 63 | 52.6 | 1.20 | 0.00000343 | 428 |
| Loss of Function | 0.332 | 7 | 8.01 | 0.874 | 3.46e-7 | 106 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.00014 | 0.00014 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00013 | 0.00013 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0.00049 | 0.00049 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: PPIase that catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides and may therefore assist protein folding. {ECO:0000269|PubMed:20676357}.;
- Disease
- DISEASE: Osteogenesis imperfecta 9 (OI9) [MIM:259440]: A form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI9 is a severe autosomal recessive form of the disorder. {ECO:0000269|PubMed:19781681, ECO:0000269|PubMed:20089953}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.400
Intolerance Scores
- LoFtool
- 0.665
- RVIS EVS
- -0.34
- RVIS percentile EVS
- 30.07
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.644
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |